z-logo
open-access-imgOpen Access
Tumor Necrosis Factor Alpha SNP Variant in Promoter Region G308a, cause Preeclampsia during Pregnancy in Pakistani Women, A Case Control Study
Author(s) -
Azizah Ziauddin,
Saeed Ahmad,
Asad Iqbal,
Abdul Majid Khan,
Shahid Mahmood
Publication year - 2020
Publication title -
journal of bioresource management
Language(s) - English
Resource type - Journals
ISSN - 2309-3854
DOI - 10.35691/jbm.0202.0154
Subject(s) - preeclampsia , single nucleotide polymorphism , genotyping , pregnancy , medicine , snp , genotype , snp genotyping , genetic predisposition , gastroenterology , immunology , obstetrics , disease , biology , genetics , gene
Preeclampsia (PE) is a very common critical condition during pregnancy. As PE is a high-risk condition during pregnancy, occurring in 25% of all pregnancies, worldwide. In women with PE there is an increase in hypertension and albuminuria. Elevated blood pressure can be life-threatening after 20th week of pregnancy. Single nucleotide variation in gene sequence can be disease causing, among these pathogenic SNPs, a variant in TNF-α, G308A is analyzed in many studies as a causative variant to cause preeclampsia. In this case control study fifty patients and fifty healthy individuals were enrolled for analysis of TNF-α promoter region SNP G308A from Jinnah hospital, Lahore, Pakistan. The genotyping of TNF-α (G308A) rs1800629 polymorphisms was performed by PCR-RFLP method. Data analysis was performed by using SNPStats, statistical tool. The mean age of all patients and controls were calculated, 24.4 ± 6.6 and 25.1 ± 5.3 years, respectively. The frequency of G308A polymorphism was more prevalent in the case group, in association with control group (p<0.001). There was a significant correlation between inflammation promoting genotypes of TNF-α and PE. It can be warily concluded that: TNF- α (G-308A) polymorphism can be reflected as a marker of predisposition to preeclampsia in our population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here